Lebrikizumab-lbkz.

IF 2.1 4区医学 Q3 PHARMACOLOGY & PHARMACY American Journal of Health-System Pharmacy Pub Date : 2024-11-19 DOI:10.1093/ajhp/zxae326

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Lebrikizumab-lbkz.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

American Journal of Health-System Pharmacy 医学-药学

CiteScore

2.90

自引率

18.50%

发文量

341

审稿时长

3-8 weeks

期刊介绍： The American Journal of Health-System Pharmacy (AJHP) is the official publication of the American Society of Health-System Pharmacists (ASHP). It publishes peer-reviewed scientific papers on contemporary drug therapy and pharmacy practice innovations in hospitals and health systems. With a circulation of more than 43,000, AJHP is the most widely recognized and respected clinical pharmacy journal in the world.

期刊最新文献

Arimoclomol Citrate. Lebrikizumab-lbkz. Pharmacy Futures: Summit on Artificial Intelligence in Pharmacy Practice. Advancing the role of pharmacists in infectious diseases: Fostering critical thinking and collaboration. Implementation of a university-wide health-system collaborative to provide pharmacy preceptor development across multiple institutions.